REVALOR®-H
REVALOR®-H increases rate of weight gain and improves feed efficiency in a slow-release, single implant delivery system
LEARN MOREPRESTIGE® 3 + WNV
For the vaccination of healthy horses 6 months or older against Eastern and Western encephalomyelitis viruses, tetanus and West Nile Virus
LEARN MOREIMIZOL®
For the treatment of dogs with clinical signs of babesiosis and/or demonstrated Babesia organisms in the blood.
LEARN MOREREVALOR®-G
REVALOR® -G is used in more stocker cattle than any other brand. In fact, it leads the next closest implant brand by a more than 2-to-1 margin.
LEARN MOREREVALOR®-200
As part of an aggressive implant strategy, REVALOR® -200 increases rate of gain and improves feed efficacy in feedlot cattle.
LEARN MOREPROTAZIL® (1.56% diclazuril) Antiprotozoal Pellets
PROTAZIL Antiprotozoal Pellets are indicated for the treatment of equine protozoal myeloencephalitis caused by Sarcocystis neurona in horses.
LEARN MOREPRESTIGE® TETANUS (Tetanus)
Shown to be effective for the vaccination of healthy horses, cattle, swine and sheep 6 months of age or older against tetanus.
LEARN MOREPRESTIGE® PRODIGY® (EHV-1, reproductive/respiratory)
Shown to be effective for the vaccination of healthy horses 6 months of age or older against abortion and respiratory disease caused by EHV-1
LEARN MOREPRESTIGE® EQUIRAB®
Shown to be effective for the vaccination of healthy horses 4 months of age or older against rabies virus.
LEARN MOREPRESTIGE® 5 + WNV
For the vaccination of healthy horses 6 months or older against EEE and WEE viruses, EIV, EHV-1, EHV-4, tetanus and West Nile Virus.
LEARN MOREPRESTIGE® 5
For the vaccination of healthy horses 6 months or older against EEE and WEE viruses, EIV, EHV-1, EHV-4, and tetanus.
LEARN MOREPRESTIGE® 4
For the vaccination of healthy horses 6 months or older against Eastern and Western encephalomyelitis, equine influenza virus and tetanus.
LEARN MORE
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global